WANBURYNSEWanbury Limited· PharmaceuticalsLowNeutral
Announced Tue, 2 Jun · 12:18 IST

Wanbury Limited has informed the Exchange regarding a press release dated June 02, 2026, titled "Press Release on Q4 & Year ended FY 2026 Audited Financial Results".

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹265.00
prior close
₹261.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-1.1-1.5-1.3-2.3-2.6+0.0-3.6+0.4-3.2+5.8+7.8
Up moveDown movePending
AI summary

Wanbury Limited has informed the stock exchange about a press release dated June 02, 2026, covering its Q4 (January–March 2026) and full-year FY 2026 audited financial results. The actual financial numbers and detailed performance are contained in the referenced press release rather than this filing itself. This is a routine disclosure made to comply with listing requirements after the audited results are finalized. Investors will need to look at the linked press release to see revenue, profit/loss, and other key metrics for the quarter and year.

Likely market impact

The filing itself only signals that audited results have been formally released; the actual impact on the stock or shareholders will depend on the numbers reported in the press release, which may drive near-term price movement once the market digests them.